Pain Management

The American College of Medical Toxicology recently issued position statements on opioid prescribing.

More than 100 million Americans experience pain each day, and it has been associated with a $500 billion economic burden in the United States.

Whether transient, spontaneous, or a triggered exacerbation of adequately controlled baseline aches, breakthrough pain is a difficult symptom for providers to gauge.

Data from large survey reports suggest that more than 80% of Americans who undergo surgery experience some level of postsurgical pain.

Overdose deaths involving opioids are on the rise in the United States.

Because patients are getting varicella vaccines, it is necessary for them to receive the zoster vaccine once they reach the appropriate age.

Neuropathic pain is one of the most difficult syndromes to treat.

Retrospective drug utilization review programs can reduce potentially unsafe concomitant opioid and central nervous system (CNS) medication use.

Black children with severe pain are less likely to receive opioids in emergency departments than white children, a recent study suggests.

The placebo effect is growing stronger in US clinical trials for chronic pain medications, according to a recent study.

Citing a rare, yet serious risk of slowed breathing, the FDA is evaluating the use of the opioid pain medication tramadol in the pediatric population.

Touted as a way to reduce pain, speed injury recovery, and improve mood, cryotherapy involves exposing the body to temperatures up to minus 300 degrees Fahrenheit.

Patients take acetaminophen and ibuprofen for minor pain and fever, but are they interchangeable?

Many sleepwalkers who injure themselves during their sleep do not experience pain until the next morning, which may lead them to the pharmacy for OTC pain relief.

The FDA has accepted Espero Pharmaceuticals' new drug application for GoNitro, a product designed to treat an attack or prophylaxis of angina pectoris due to coronary artery disease.

Treating low back pain with physical therapy soon after symptoms start does not make a clinically important difference when compared with starting therapy later.

The FDA has approved Endo Pharmaceuticals and BioDelivery Sciences' buprenorphine buccal film (Belbuca) for the management of chronic pain.

Pain is recognized as a common, but complex, multifaceted experience that can interfere with quality of life and contribute to psychological problems, social awkwardness, and work-related disability.

A recent study has found that brain inflammation caused by chronic nerve pain alters activity in the mood-regulating regions of the brain.

Black children with severe pain are less likely to receive opioids in emergency rooms than white children.

The placebo effect is growing stronger in US clinical trials for chronic pain medications.

When you have 99.99% awesome patients, a pharmacist's job is fun to do.

Citing a rare yet serious risk of slowed breathing, the FDA is evaluating the use of the opioid pain medication tramadol (Ultram, Ultram ER, Conzip) in the pediatric population.

Pregabalin and gabapentin are often considered first-line treatments for various neuropathic pain syndromes, generally irrespective of cause.

Draft guidelines from the US Centers for Disease Control and Prevention (CDC) could sharply reduce the role opioids play in primary care-based pain management.